-
1Academic Journal
Συγγραφείς: A. V. Vlasova, Yu. F. Shubina, I. R. Gaziev, D. A. Sychev, А. В. Власова, Ю. Ф. Шубина, И. Р. Газиев, Д. А. Сычев
Συνεισφορές: The study was performed without external funding, Работа выполнена без спонсорской поддержки
Πηγή: Safety and Risk of Pharmacotherapy; Том 12, № 2 (2024); 167-177 ; Безопасность и риск фармакотерапии; Том 12, № 2 (2024); 167-177 ; 2619-1164 ; 2312-7821 ; 10.30895/2312-7821-2024-12-2
Θεματικοί όροι: SLCO1B1, antibiotics, tigecycline, meropenem, drug-induced liver disease, adverse drug reactions, pharmacogenetics, CYP3A5, антибиотики, тигециклин, меропенем, лекарственно-индуцированные заболевания печени, нежелательные реакции, фармакогенетика
Περιγραφή αρχείου: application/pdf
Relation: https://www.risksafety.ru/jour/article/view/392/1153; https://www.risksafety.ru/jour/article/downloadSuppFile/392/462; https://www.risksafety.ru/jour/article/downloadSuppFile/392/471; https://www.risksafety.ru/jour/article/downloadSuppFile/392/528; Yu Y, Nie X, Song Z, Xie Y, Zhang X, Du Z, et al. Signal detection of potentially drug-induced liver injury in children using electronic health records. Front Pediatr. 2020;8:171. https://doi.org/10.3389/fped.2020.00171; Yu Z, Zhao Y, Jin J, Zhu J, Yu L, Han G. Prevalence and risk factors of tigecycline-induced liver injury: a multicenter retrospective study. Int J Infect Dis. 2022;120:59–64. https://doi.org/10.1016/j.ijid.2022.04.024; Baietto L, Corcione S, Pacini G, Perri GD, D’Avolio A, De Rosa FG. A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics? Curr Drug Metab. 2014;15(6):581–98. https://doi.org/10.2174/1389200215666140605130935; Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis. 2009;29(4):400–11. https://doi.org/10.1055/s-0029-1240009; Zed PJ, Haughn C, Black KJL, Fitzpatrick EA, Ackroyd-Stolarz S, Murphy NG, et al. Medication-related emergency department visits and hospital admissions in pediatric patients: a qualitative systematic review. J Pediatr. 2013;163(2):477–83. https://doi.org/10.1016/j.jpeds.2013.01.042; Ersulo TA, Yizengaw MA, Tesfaye BT. Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study. BMC Pharmacol Toxicol. 2022;23(1):30. https://doi.org/10.1186/s40360-022-00570-w; Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology. 2011;141(1):338–47. https://doi.org/10.1053/j.gastro.2011.04.001; Alshabeeb M, Alomar FA, Khan A. Impact of SLCO1B1*5 on flucloxacillin and co-amoxiclav-related liver injury. Front Pharmacol. 2022;13:882962. https://doi.org/10.3389/fphar.2022.882962; Власова АВ, Шубина ЮФ, Сычев ДА. Лекарственное поражение печени, ассоциированное с антибиотиками, у детей в критических состояниях: проспективное наблюдательное исследование. Безопасность и риск фармакотерапии. 2024. https://doi.org/10.30895/2312-7821-2023-389; Manolis E, Musuamba FT, Karlsson KE. The European Medicines Agency experience with pediatric dose selection. J Clin Pharmacol. 2021;61:S22–S27. https://doi.org/10.1002/jcph.1863; Иващенко ДВ, Буромская НИ, Савченко ЛМ, Шевченко ЮС, Сычев ДА. Значение метода глобальных триггеров для выявления неблагоприятных событий, связанных с оказанием медицинской помощи в педиатрии. Медицинский совет. 2018;(17):56–65. https://doi.org/10.21518/2079-701X-2018-17-56-65; Власова АВ, Смирнова ЕВ, Горев ВВ, Сычев ДА. Нежелательные реакции детей на антимикробные препараты: ограничения метода спонтанных сообщений и возможности метода глобальных триггеров лекарственно-индуцированных состояний. Фарматека. 2023;30(1/2):18–31. https://doi.org/10.18565/pharmateca.2023.1-2.18-31; Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. “Global Trigger Tool” shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood). 2011;30(4):581–9. https://doi.org/10.1377/hlthaff.2011.0190; Katarey D, Verma S. Drug-induced liver injury. Clin Med. 2016;16(Suppl 6):S104–S109. https://doi.org/10.7861/clinmedicine.16-6-s104; Yu Y, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, et al. CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11(3):221–41. https://doi.org/10.1007/s12072-017-9793-2; Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology. 2014;60(3):1015–22. https://doi.org/10.1002/hep.27206; Darwish MH, Farah RA, Farhat GN, Torbey PH, Ghandour FA, Bejjani-Doueihy NA, Dhaini HR. Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma. Mol Med Rep. 2015;11(2):1462–8. https://doi.org/10.3892/mmr.2014.2835; Kameyama Y, Yamashita K, Kobayashi K, Hosokawa M, Chiba K. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics. 2005;15(7):513–22. https://doi.org/10.1097/01.fpc.0000170913.73780.5f; Jindal C, Kumar S, Choudhari G, Goel H, Mittal B. Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) and susceptibility in gallstone disease. Indian J Med Res. 2009;129(2):170–5. PMID: 19293444; https://www.risksafety.ru/jour/article/view/392
-
2Academic Journal
Συγγραφείς: A. V. Vlasova, Yu. F. Shubina, D. A. Sychev, А. В. Власова, Ю. Ф. Шубина, Д. А. Сычев
Συνεισφορές: The study was performed without external funding, Работа выполнена без спонсорской поддержки
Πηγή: Safety and Risk of Pharmacotherapy; Том 12, № 2 (2024); 155-166 ; Безопасность и риск фармакотерапии; Том 12, № 2 (2024); 155-166 ; 2619-1164 ; 2312-7821 ; 10.30895/2312-7821-2024-12-2
Θεματικοί όροι: клиническое исследование, antibiotics, drug-induced liver diseases, DILI, hepatotoxicity, cholestatic hepatitis, adverse drug reactions, Global Trigger Tool, clinical trial, антибиотики, лекарственно-индуцированные заболевания печени, гепатотоксичность, холестатический гепатит, нежелательные реакции, метод глобальных триггеров
Περιγραφή αρχείου: application/pdf
Relation: https://www.risksafety.ru/jour/article/view/389/1152; https://www.risksafety.ru/jour/article/downloadSuppFile/389/379; Amin MD, Harpavat S, Leung DH. Drug-induced liver injury in children. Curr Opin Pediatr. 2015;27(5):625–33. https://doi.org/10.1097/mop.0000000000000264; Lee HH, Ho RH. Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1). Br J Clin Pharmacol. 2017;83(6):1176–84. https://doi.org/10.1111/bcp.13207; Katarey D, Verma S. Drug-induced liver injury. Clin Med (Lond). 2016;16(Suppl. 6):s104–s109. https://doi.org/10.7861/clinmedicine.16-6-s104; Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, et al. Indian national association for the study of the liver consensus statement on acute liver failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10(4):339–76. https://doi.org/10.1016/j.jceh.2020.04.012; Donati M, Motola D. Leone R, Moretti U, Stoppa G, Arzenton E, et al. Liver injury due to amoxicillin vs. amoxicillin/clavulanate: a subgroup analysis of a drug-induced liver injury case-control study in Italy. J Hepatol Gastroint Dis. 2017;3(2):1–5. https://doi.org/10.4172/2475-3181.1000143; Teixeira M, Macedo S, Batista T, Martins S, Correia A, Costa Matos L. Flucloxacillin-induced hepatotoxicity-association with HLA-B*5701. Rev Assoc Med Bras (1992). 2020;66(1):12–7. https://doi.org/10.1590/1806-9282.66.1.12; Yu Y, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, et al. CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11(3):221–41. https://doi.org/10.1007/s12072-017-9793-2; Zhou Y, Yang L, Liao Z, He X, Zhou Y, Guo H. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21789 patients. Eur J Gastroenterol Hepatol. 2013;25(7):825–9. https://doi.org/10.1097/meg.0b013e32835f6889; Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36(2):451–5. https://doi.org/10.1053/jhep.2002.34857; Pinna AP, Locci G, Furno M, Fanni D, Faa G, Nurchi AM. DILI (drug-induced liver injury) in a 9-month-old infant: a rare case of phenobarbital-induced hepatotoxicity. J Pediatr Neonatal Individ Med JPNIM. 2013;2:93–5. https://doi.org/10.7363/020114; Sridharan K, Al Daylami A, Ajjawi R, Al Ajooz HA. Drug-induced liver injury in critically ill children taking antiepileptic drugs: a retrospective study. Curr Ther Res Clin Exp. 2020;92:100580. https://doi.org/10.1016/j.curtheres.2020.100580; Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512–21. https://doi.org/10.1016/j.gastro.2005.05.006; Chalasani N, Reddy K, Fontana R, Barnhart H, Gu J, Hayashi P, et al. Idiosyncratic drug-induced liver injury in African-Americans is associated with greater morbidity and mortality compared to Caucasians. Am J Gastroenterol. 2017;112(9):1382–8. https://doi.org/10.1038/ajg.2017.215; Björnsson ES. Hepatotoxicity of statins and other lipid-lowering agents. Liver Int. 2017;37(2):173–8. https://doi.org/10.1111/liv.13308; deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart HX, Fontana RJ, et al. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016;61(8):2406–16. https://doi.org/10.1007/s10620-016-4121-6; Iannelli V. 30 most commonly prescribed pediatric medications. 06.06.2023. https://www.verywellhealth.com/the-30-most-prescribed-drugs-in-pediatrics-2633435; Yamaguchi A, Tateishi T, Okano Y, Matuda T, Akimoto Y, Miyoshi T, et al. Higher incidence of elevated body temperature or increased C-reactive protein level in asthmatic children showing transient reduction of theophylline metabolism. J Clin Pharmacol. 2000;40(3):284–9. https://doi.org/10.1177/00912700022008955; Pokrajac M, Simić D, Varagić V. Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease. Eur J Clin Pharmacol. 1987;33(5):483–6. https://doi.org/10.1007/bf00544240; Stephens M, Self T, Lancaster D, Nash T. Hypothyroidism: effect on warfarin anticoagulation. South Med J. 1989;82(12):1585–6. PMID: 2595433; Ersulo TA, Yizengaw MA, Tesfaye BT. Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study. BMC Pharmacol Toxicol. 2022;23(1):30. https://doi.org/10.1186/s40360-022-00570-w; Kiguba R, Karamagi C, Bird SM. Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients. BMJ Open. 2017;7(1):e010568. https://doi.org/10.1136/bmjopen-2015-010568; Zed PJ, Haughn C, Black KJL, Fitzpatrick EA, Ackroyd-Stolarz S, Murphy NG, et al. Medication-related emergency department visits and hospital admissions in pediatric patients: a qualitative systematic review. J Pediatr. 2013;163(2):477–83. https://doi.org/10.1016/j.jpeds.2013.01.042; Schumaker AL, Okulicz JF. Meropenem-induced vanishing bile duct syndrome. Pharmacotherapy. 2010;30(9):953. https://doi.org/10.1592/phco.30.9.953; Doß S, Blessing C, Haller K, Richter G, Sauer M. Influence of antibiotics on functionality and viability of liver cells in vitro. Curr Issues Mol Biol. 2022;44(10):4639–57. https://doi.org/10.3390/cimb44100317; Li L-M, Chen L, Deng G-H, Tan W-T, Dan Y-J, Wang R-Q, Chen W-S. SLCO1B1*15 haplotype is associated with rifampin-induced liver injury. Mol Med Rep. 2012;6(1):75–82. https://doi.org/10.3892/mmr.2012.900; Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH, Kleiner DE, et al. Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol. 2013;11(5):558–64. https://doi.org/10.1016/j.cgh.2012.12.025; Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007;4(1):37–45. https://doi.org/10.1517/17425247.4.1.37; Buch S, Schafmayer C, Voelzke H, Seeger M, Miquel JF, Sookoian SC, et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology. 2010;139(6):1942–51. https://doi.org/10.1053/j.gastro.2010.09.003; Hoofnagle JH, Björnsson ES. Drug-induced liver injury — types and phenotypes. N Engl J Med. 2019;381(3):264–73. https://doi.org/10.1056/nejmra1816149; Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis. 2009;29(4):400–11. https://doi.org/10.1055/s-0029-1240009; Manolis E, Musuamba FT, Karlsson KE. The European Medicines Agency experience with pediatric dose selection. J Clin Pharmacol. 2021;61:S22–S27. https://doi.org/10.1002/jcph.1863; Власова АВ, Смирнова ЕВ, Горев ВВ, Сычев ДА. Нежелательные реакции детей на антимикробные препараты: ограничения метода спонтанных сообщений и возможности метода глобальных триггеров лекарственно-индуцированных состояний. Фарматека. 2023;30(1–2):18–31. https://doi.org/10.18565/pharmateca.2023.1-2.18-31; Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. ‘Global Trigger Tool’ shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood). 2011;30(4):581–9. https://doi.org/10.1377/hlthaff.2011.0190; Иващенко ДВ, Буромская НИ, Савченко ЛМ, Шевченко ЮС, Сычев ДА. Значение метода глобальных триггеров для выявления неблагоприятных событий, связанных с оказанием медицинской помощи в педиатрии. Медицинский совет. 2018;(17):56–65. https://doi.org/10.21518/2079-701X-2018-17-56-65; Johnson AD, Kavousi M, Smith AV, Chen M-H, Dehghan A, Aspelund T, et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet. 2009;18(14):2700–10. https://doi.org/10.1093/hmg/ddp202; Yu Y, Nie X, Song Z, Xie Y, Zhang X, Du Z, et al. Signal detection of potentially drug-induced liver injury in children using electronic health records. Front Pediatr. 2020;8:171. https://doi.org/10.3389/fped.2020.00171; Jiang T, Huang X, Liu Q, Feng H, Huang Y, Lin J, et al. Risk factors for tigecycline-associated hepatotoxicity in patients in the intensive care units of 2 tertiary hospitals: a retrospective study. J Clin Pharmacol. 2022;62(11):1426–34. https://doi.org/10.1002/jcph.2099; Ghanem CI, Gómez PC, Arana MC, Perassolo M, Ruiz ML, Villanueva SS, et al. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Biochem Pharmacol. 2004;68(4):791–8. https://doi.org/10.1016/j.bcp.2004.05.014; Acevedo C, Bengochea L, Tchercansky DM, Ouviña G, Perazzo JC, Lago N, et al. Cholestasis as a liver protective factor in paracetamol acute overdose. Gen Pharmacol. 1995;26(7):1619–24. https://doi.org/10.1016/0306-3623(95)00061-5; https://www.risksafety.ru/jour/article/view/389